Carmen Schade-Brittinger
2 clinical trials · Sponsor
◉ Watch Carmen Schade-Brittinger
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Therapy of Gemcitabine and Erbitux® to R0 or R1 Resected Pancreatic Cancer (NCT00395252) | Carmen Schade-Brittinger | 2006-10-01 |
| Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut (NCT00171873) | Carmen Schade-Brittinger | 2001-09-01 |
Track Carmen Schade-Brittinger automatically
Every clearance here is in the API, with alerts when new ones post.